Coriell Life Sciences, Inc.

PHILADELPHIA, PA · Founded 2013 · CIK 0001675480 · Biotech · Acquired

Biobank and repository providing high-quality biological samples (stem cells, iPSCs, cell lines, DNA, RNA, tissue) and custom laboratory services for research

coriell.org →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$10M
2 Form D · May 2019
89 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$605,000
Private capital raisedForm D · SEC$9,467,925
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2831Inceptive Nucleics, Inc.—$100M
2832Arena Pharmaceuticals—$187M
2833Prelude Therapeutics—$97M
2834Coriell Life Sciences, Inc.—$10M
2835Tango Therapeutics—$95M
2836Arcutis Biotherapeutics, Inc.—$94M
2837OMNI BIO PHARMACEUTICAL, INC.—$28M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Dr. Stephen AndrioleDirector
  • Stephen AndrioleDirector
  • Michael ChristmanDirector
  • Peter DriscollDirector
  • Scott MegillDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.